Myeloma Canada is a non-profit, charitable organization created by, and for people impacted by multiple myeloma, a relatively unknown cancer of the plasma cells. Exclusively devoted to the Canadian myeloma community, Myeloma Canada has been making myeloma matter since 2005. As a patient-driven, patient-focused grassroots organization, Myeloma Canada drives collaborative efforts to unify the voice of the community to effectively shape the Canadian treatment landscape with a committed focus on the improvement of patient outcomes.
- GSK provided a core funding of $24,000 for their Covid-19 initiatives.
- GSK provided a conference sponsorship of $20,000 (Scientific Roundtable: Making Myeloma Matter).
Our support represented less than 3% of their overall income.